Raphael A Nemenoff

11PUBLICATIONS
35CO-AUTHORS
Molecular targetsPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumoursInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 21, 2026
Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases.

|Mar 27, 2026
Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusions.

Maria J Contreras-Zárate, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz

|Aug 14, 2025
Orthotopically Implanted Murine Lung Adenocarcinoma Cell Lines for Preclinical Investigations.

Karshana J Kalyanaraman, Zachary Corey, Andre Navarro

|Feb 05, 2023
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity.

Emily K Kleczko, Trista K Hinz, Teresa T Nguyen

|May 18, 2021
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.

Natalia J Gurule, Caroline E McCoach, Trista K Hinz

|May 14, 2021
Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular remodelling.

Austin J Jolly, Sizhao Lu, Keith A Strand

Pageof 2

Frequent Collaborators

4 joint publications

Emily K Kleczko

3 joint publications

Eric T Clambey

3 joint publications

Lynn E Heasley

3 joint publications

Amber M Johnson